Validation of the 2018 FIGO Staging System for Predicting the Prognosis of Patients With Stage IIIC Cervical Cancer.

Xingtao Long Misi HeLingling YangDongling ZouDong WangYuemei ChenQi Zhou

Published in: Clinical Medicine Insights. Oncology (2023)

Patients with stage IIIC1 cervical cancer showed heterogeneous clinical characteristics that reflected variable prognoses, depending on the T stage and the extent of pelvic lymph node metastases.

Keyphrases

lymph node
neoadjuvant chemotherapy
squamous cell carcinoma
rectal cancer
radiation therapy
early stage
locally advanced